{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:08:51Z","timestamp":1779422931190,"version":"3.53.1"},"reference-count":100,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Alzheimer's disease (AD) is a progressive neurological illness that causes cognitive deterioration. Current medications only help with the symptoms to a limited extent. Over the past decade, nucleoside reverse transcriptase inhibitors (NRTIs), historically used as antiretrovirals, have appeared as surprising contenders for modifying\n                    <jats:sc>AD<\/jats:sc>\n                    . Aside from their antiviral activity, NRTIs have immunomodulatory actions, such as inhibiting the NLRP3 inflammasome, lowering amyloid and tau pathology and modulating neuroinflammation. A second\u2010generation analogue, Kamuvudine\u20109, has been designed to balance these neuroprotective advantages with reduced mitochondrial toxicity and off\u2010target antiviral effects, offering a safer long\u2010term solution for chronic neurodegenerative disorders. This review synthesises mechanistic data, preclinical data, observational studies and new clinical findings to make a unified case for NRTIs and K\u20109 as multitarget therapeutic compounds in\n                    <jats:sc>AD<\/jats:sc>\n                    . By emphasising their dual mechanism, retroelement inhibition and inflammasome blockade coupled with innovation in drug delivery and pharmacogenomics, we highlight how repurposing this class would remake the therapeutic landscape. In contrast to amyloid\u2010directed interventions, NRTIs and K\u20109 act on converging inflammatory and genetic mechanisms that mediate both amyloid and tau pathology, making them universal modulators of disease course. Prospects for future advances in precision medicine, nanocarrier delivery and large\u2010scale validation of interventions may reveal a new generation of accessible, disease\u2010modifying treatments for\n                    <jats:sc>AD<\/jats:sc>\n                    .\n                  <\/jats:p>","DOI":"10.1111\/fcp.70079","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:03:41Z","timestamp":1774515821000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting Neuroinflammation in Alzheimer's Disease: Repurposed Nucleoside Reverse Transcriptase Inhibitors and the Therapeutic Potential of Kamuvudine\u20109"],"prefix":"10.1111","volume":"40","author":[{"given":"Mariyam","family":"Hussain","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Education and Research Jamia Hamdard  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ikram","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Education and Research Jamia Hamdard  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Education and Research Jamia Hamdard  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"e_1_2_17_2_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2000.2.2\/asschachter"},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2018.01.003"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12694"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.56"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.02.001"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.4c00339"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.08.010"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061117"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035\u2010024\u201004285\u20103"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024\u2010025\u201000828\u2010x"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11729"},{"key":"e_1_2_17_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392\u2010020\u20100145\u20107"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2009680117"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s44400\u2010025\u201000011\u20105"},{"key":"e_1_2_17_16_1","doi-asserted-by":"crossref","unstructured":"D.Harrison A.Billinton M. G.Bock et\u00a0al. \u201cProfile of NT\u20100527 a Brain Penetrant NLRP3 Inflammasome Inhibitor Suitable as an In\u00a0Vivo Tool Compound for Neuroinflammatory Disorders \u201d RSC Medicinal Chemistry. (2025):https:\/\/doi.org\/10.1039\/D5MD00639B.","DOI":"10.1039\/D5MD00639B"},{"key":"e_1_2_17_17_1","unstructured":"Ventus Therapeutics US Inc \u201cA Randomized Double\u2010Blind Placebo\u2010Controlled Phase 1b Study of the NLRP3 Inhibitor VENT\u201002 in Patients With Mild to Moderate Parkinson's Disease \u201d (2025) clinicaltrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06822517."},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13789"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1257700"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168979"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903066780"},{"key":"e_1_2_17_22_1","unstructured":"K.Lieb \u201cQuantitative Analysis of the Expression of Dementia\u2010Relevant Genes by Intake of the Drug Disulfiram \u201d (2017) clinicaltrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03212599."},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70180"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17040408"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010206103"},{"key":"e_1_2_17_26_1","volume-title":"StatPearls","author":"Patel P. H.","year":"2025"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.2165\/11640830\u2010000000000\u201000000"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570162X15666171120110145"},{"key":"e_1_2_17_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7101-5_442"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03412\u201024"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29133121"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586\u2010019\u20101769\u2010z"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035\u2010013\u20108475\u2010x"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.570711"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1935"},{"key":"e_1_2_17_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1636"},{"key":"e_1_2_17_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109941"},{"key":"e_1_2_17_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2007.06.006"},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD\u2010230273"},{"key":"e_1_2_17_40_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673\u20105374.391311"},{"key":"e_1_2_17_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035\u2010023\u201003847\u20101"},{"key":"e_1_2_17_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010017\u201003446\u2010w"},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149\u20102918(00)90004\u20103"},{"key":"e_1_2_17_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv424"},{"key":"e_1_2_17_45_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.749473"},{"key":"e_1_2_17_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16121592"},{"issue":"4","key":"e_1_2_17_47_1","first-page":"432","article-title":"How Much Do Antiretroviral Drugs Penetrate Into the Central Nervous System?","volume":"4","author":"Ene L.","year":"2011","journal-title":"Journal of Medicine and Life"},{"key":"e_1_2_17_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.454"},{"key":"e_1_2_17_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12661"},{"key":"e_1_2_17_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2022.2112175"},{"key":"e_1_2_17_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2504\u20102506.2005"},{"key":"e_1_2_17_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318247ec54"},{"key":"e_1_2_17_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70120"},{"key":"e_1_2_17_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111187"},{"key":"e_1_2_17_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241311144"},{"key":"e_1_2_17_56_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD\u2010181259"},{"key":"e_1_2_17_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035\u2010020\u201001904\u20107"},{"key":"e_1_2_17_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2020.101838"},{"key":"e_1_2_17_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11481\u2010018\u20109777\u20106"},{"key":"e_1_2_17_60_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100620"},{"key":"e_1_2_17_61_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23\u201005\u201001605.2003"},{"key":"e_1_2_17_62_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0621\u201017.2017"},{"key":"e_1_2_17_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3893"},{"key":"e_1_2_17_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577\u2010019\u20100165\u20100"},{"key":"e_1_2_17_65_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1261754"},{"key":"e_1_2_17_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13798"},{"key":"e_1_2_17_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035\u2010023\u201003699\u20109"},{"key":"e_1_2_17_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380\u2010020\u201000965\u20103"},{"key":"e_1_2_17_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.09.040"},{"key":"e_1_2_17_70_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15\u201017440"},{"key":"e_1_2_17_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00038"},{"key":"e_1_2_17_72_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00005"},{"key":"e_1_2_17_73_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c02249"},{"key":"e_1_2_17_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102878"},{"key":"e_1_2_17_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010020\u201018528\u2010z"},{"key":"e_1_2_17_76_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.613449"},{"key":"e_1_2_17_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040909"},{"key":"e_1_2_17_78_1","doi-asserted-by":"publisher","DOI":"10.1139\/bcb\u20102023\u20100134"},{"key":"e_1_2_17_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094368"},{"key":"e_1_2_17_80_1","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2025.152369"},{"key":"e_1_2_17_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70296"},{"key":"e_1_2_17_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11302\u2010025\u201010104\u20108"},{"key":"e_1_2_17_83_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.5.3"},{"key":"e_1_2_17_84_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01004"},{"key":"e_1_2_17_85_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1376681"},{"key":"e_1_2_17_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17411"},{"key":"e_1_2_17_87_1","doi-asserted-by":"crossref","unstructured":"J.Magagnoli P.Yerramothu K.Ambati et\u00a0al. \u201cReduction of Human Alzheimer's Disease Risk and Reversal of Mouse Model Cognitive Deficit With Nucleoside Analog Use \u201d (2023) medRxiv Prepr Serv Health Sci 2023.03.17.23287375 https:\/\/doi.org\/10.1101\/2023.03.17.23287375.","DOI":"10.1101\/2023.03.17.23287375"},{"key":"e_1_2_17_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392\u2010021\u201000537\u2010z"},{"key":"e_1_2_17_89_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.21.2819"},{"key":"e_1_2_17_90_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.62.1.66"},{"key":"e_1_2_17_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2025.04.001"},{"key":"e_1_2_17_92_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071687"},{"key":"e_1_2_17_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.20223"},{"key":"e_1_2_17_94_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00039\u201007"},{"key":"e_1_2_17_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2006.09.010"},{"key":"e_1_2_17_96_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.722204"},{"key":"e_1_2_17_97_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16121661"},{"key":"e_1_2_17_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22900"},{"key":"e_1_2_17_99_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2012.678048"},{"key":"e_1_2_17_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2015.07.048"},{"key":"e_1_2_17_101_1","doi-asserted-by":"publisher","DOI":"10.1039\/D5RA03578C"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.70079","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/fcp.70079","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.70079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T03:38:15Z","timestamp":1779421095000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/fcp.70079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1111\/fcp.70079"],"URL":"https:\/\/doi.org\/10.1111\/fcp.70079","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"2025-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70079"}}